Vir Biotechnology (VIR) Current Leases (2019 - 2023)

Vir Biotechnology's Current Leases history runs 4 years deep, the most recent figure standing at $7.3 million for Q1 2023.

• In Q1 2023, Current Leases changed N/A year-over-year to $7.3 million; the TTM figure through Mar 2023 stood at $7.3 million (changed N/A YoY), while the FY2022 annual figure was $4.1 million, changed N/A from the prior year.
• Current Leases came in at $7.3 million for Q1 2023 at Vir Biotechnology, up from $4.1 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $7.3 million in Q1 2023 to a low of $200000.0 in Q1 2020.
• A 4-year average of $1.8 million and a median of $253000.0 in 2020 frame the typical range for Current Leases.
• On a YoY basis, Current Leases climbed as much as 11.81% in 2020 and fell as far as 11.81% in 2020.
• Vir Biotechnology's Current Leases stood at $237000.0 in 2019, then increased by 11.81% to $265000.0 in 2020, then jumped by 1461.13% to $4.1 million in 2022, then soared by 75.68% to $7.3 million in 2023.
• According to Business Quant data, Current Leases over the past three periods registered $7.3 million, $4.1 million, and $265000.0 for Q1 2023, Q4 2022, and Q4 2020 respectively.

Peer Comparison